Old Web
English
Sign In
Acemap
>
Paper
>
Jury still out on whether FGF23 is a direct contributor, a useful biomarker, or neither.
Jury still out on whether FGF23 is a direct contributor, a useful biomarker, or neither.
2021
Hirotaka Komaba
Masafumi Fukagawa
Keywords:
Oncology
Medicine
Biomarker (medicine)
Internal medicine
Jury
Correction
Source
Cite
Save
Machine Reading By IdeaReader
15
References
1
Citations
NaN
KQI
[]